Lise Hejl Hyldstrup
Overview
Explore the profile of Lise Hejl Hyldstrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ornbjerg L, Brahe C, Linde L, Jacobsson L, Nissen M, Kristianslund E, et al.
Joint Bone Spine
. 2024 Apr;
91(4):105729.
PMID: 38582359
Objective: To investigate real-world retention and remission rates in PsA patients initiating a 2nd or 3rd TNFi and the association with reason for discontinuation from the previous TNFi-treatment. Methods: Prospectively...
2.
Linde L, Ornbjerg L, Brahe C, Wallman J, Di Giuseppe D, Zavada J, et al.
Rheumatology (Oxford)
. 2023 Sep;
63(7):1882-1892.
PMID: 37738257
Objective: To investigate real-world effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA) and the association with (i) treatment line (second and third TNFi-series) and (ii)...
3.
Hetland M, Haavardsholm E, Rudin A, Nordstrom D, Nurmohamed M, Gudbjornsson B, et al.
BMJ
. 2020 Dec;
371:m4328.
PMID: 33268527
Objective: To evaluate and compare benefits and harms of three biological treatments with different modes of action versus active conventional treatment in patients with early rheumatoid arthritis. Design: Investigator initiated,...
4.
Michelsen B, Ornbjerg L, Kvien T, Pavelka K, Nissen M, Nordstrom D, et al.
Rheumatology (Oxford)
. 2020 Jan;
59(9):2455-2461.
PMID: 31960053
Objectives: To assess the impact of 'patient's minus evaluator's global assessment of disease activity' (ΔPEG) at treatment initiation on retention and remission rates of TNF inhibitors (TNFi) in psoriatic arthritis...
5.
Brahe C, Ornbjerg L, Jacobsson L, Nissen M, Kristianslund E, Mann H, et al.
Rheumatology (Oxford)
. 2019 Oct;
59(7):1640-1650.
PMID: 31665497
Objective: To investigate TNF inhibitor (TNFi) retention and response rates in European biologic-naïve patients with PsA. Methods: Prospectively collected data on PsA patients in routine care from 12 European registries...